The recent surge in popular discussion around ADHD – fueled by social media trends and self-diagnosis – risks fundamentally misunderstanding what it means to have ADHD, and why a formal diagnosis remains critically important. While increased awareness is generally positive, a growing narrative suggesting we all exist somewhere on an ADHD “spectrum” isn’t simply a harmless reframing; it actively diminishes the lived experiences of those who navigate life with a neurodevelopmental condition, and potentially jeopardizes access to vital support. This isn’t about gatekeeping, but about preserving the integrity of a diagnosis that, for many, unlocks a lifetime of self-understanding and improved wellbeing.
The Core Distinction: Neurodiversity as Difference, Not Degree
The crux of the matter, as Francesca Finch-Andrews of Belper, Derbyshire, powerfully articulates in a recent letter, lies in the concept of neurodiversity. ADHD and autism aren’t variations of “normal” brain function; they represent fundamentally different ways the brain is wired. Finch-Andrews, a children’s health professional diagnosed with autism at 56 and ADHD at 57, emphasizes this isn’t a matter of degree – you either possess these neurodivergences, or you don’t. The idea of a universal ADHD “tendency” implies a sliding scale where everyone exhibits some traits, minimizing the significant challenges faced by individuals with a clinical diagnosis. This isn’t to say that everyone doesn’t experience moments of inattention or impulsivity; these are universal human experiences. But for someone with ADHD, these traits are pervasive, impacting daily functioning and often co-occurring with other difficulties like anxiety or depression.
Original reporting: The Guardian.
A Late-in-Life Diagnosis: The Weight of Unknowing
Finch-Andrews’ personal story underscores the profound impact a diagnosis can have, even decades after symptoms first appear. She describes a lifetime spent unknowingly developing coping mechanisms, battling low self-esteem, and internalizing feelings of inadequacy simply because she didn’t understand why she functioned differently. This experience isn’t unique. Delayed diagnoses are common, particularly for women and individuals from marginalized communities, leading to years of unnecessary suffering. The benefit of a formal diagnosis isn’t merely a “label,” as some critics suggest, but a framework for self-acceptance and a pathway to appropriate support. Finch-Andrews’ ability to retrospectively reframe past struggles as manifestations of her neurodivergences, and to practice self-forgiveness, highlights the transformative power of understanding.
Why Casual Self-Diagnosis Can Be Harmful
The current trend of self-diagnosis, while often stemming from a genuine desire for self-understanding, carries risks. While self-help tools can be beneficial for anyone, they aren’t a substitute for a comprehensive assessment by a qualified professional. A robust diagnostic process, Finch-Andrews stresses, isn’t undertaken lightly. It involves careful evaluation to rule out other potential causes for observed symptoms and to ensure an accurate diagnosis. Furthermore, casually adopting an ADHD label can inadvertently dilute the experiences of those who have undergone this rigorous process and rely on their diagnosis for access to accommodations, medication, or therapeutic interventions. In 2023, the CDC reported that 6.1 million children (16.3%) have been diagnosed with ADHD, a figure that represents a significant population relying on accurate identification and support.
The Future of Neurodiversity Research and Access to Care
The conversation surrounding ADHD and autism is evolving, and that’s a positive development. However, the next crucial step isn’t to broaden the definition of these conditions, but to improve access to timely and accurate diagnoses, particularly for underserved populations. We need more research into the long-term impacts of delayed diagnosis and the effectiveness of different intervention strategies across the lifespan. More importantly, we need to address systemic barriers to care, such as long wait times for assessments and the high cost of treatment. What will happen if, as awareness grows, demand for diagnostic services outstrips the capacity of healthcare systems? Will we see a two-tiered system emerge, where those with resources can access timely care while others are left to navigate their neurodivergences without support? This is the question we must urgently address.
